v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Net Investment from Medtronic
Accumulated Other Comprehensive Loss
Beginning balance at Apr. 25, 2025 $ 3,330       $ 3,328 $ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (16)       (16)  
Foreign exchange translation adjustment 11          
Net transfers from Parent 212       212  
Other comprehensive income 11         11
Ending balance at Jul. 25, 2025 $ 3,537       $ 3,524 13
Beginning balance (in shares) at Apr. 24, 2026 280,819,988 280,820,000        
Beginning balance at Apr. 24, 2026 $ 3,611 $ 3 $ 3,736 $ (116)   (12)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 0     0    
Foreign exchange translation adjustment (2)         (2)
Issuance of shares under stock purchase and award plan (in shares)   180,000        
Issuance of shares under stock purchase and award plan 2   2      
Stock-based compensation 10   10      
Vesting of restricted stock units, net of shares withheld for taxes (in shares)   206,000        
Vesting of restricted stock units, net of shares withheld for taxes $ (2)   (2)      
Ending balance (in shares) at Jul. 31, 2026 281,205,548 281,206,000        
Ending balance at Jul. 31, 2026 $ 3,620 $ 3 $ 3,747 $ (116)   $ (14)